Clinical trials: Myeloma, Multiple

Multiple Myeloma

Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma

• Terminated
• Age: 20 to 79 years
• Phase 2
• Results posted

The study objectives of this study are to determine the effects, safety, and pharmacokinetics of bendamustine for multiple myeloma to a regimen of bendamustine and prednisolone.

Trial name

NCT01179490

Testing

SyB L-0501, prednisolone

Where

3 sites in Japan

Volunteers

5 people

Sponsor

SymBio Pharmaceuticals